This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
A SIMPLIFIED PEDIATRIC immunization schedule appears about ready to become a reality.
The Food and Drug Administration (FDA), Rockville, Md, has been advised by one of its review committees to license a combined diphtheria-tetanus-(whole-cell) pertussis vaccine linked with a Haemophilus influenzae type b conjugate vaccine. The result would be to reduce by half the number of injections that infants and children receive to be immunized against these diseases.
David McLintock, PhD, Lederle-Praxis Laboratories, a division of American Cyanamid Co, Wayne, NJ, says: "The two vaccines overlap in their use, being given at 2, 4, and 6 months of age with a booster at 15 to 18 months. So it was natural to combine them into a single ready-to-use vaccine."
Advisory Committee Meeting
McLintock spoke at a meeting of the advisory committee on vaccines and related biological products of the FDA's Center for Biologics and Evaluation and Research. Although there was
Marwick C. FDA Committee Recommends Combined DTP, Haemophilus influenzae Vaccine. JAMA. 1992;268(24):3415. doi:10.1001/jama.1992.03490240015004